Study title: An open study to evaluate the efficacy, safety and tolerance of the topical application of Varidase to treat patients with various kinds of open wounds with problems of inflammation, excessive accumulation of clotted blood or exudates, and tissue with necrosis.Wang et al.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Cardiovascular Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: streptokinase and streptodornase | |||||
ATC code: B06AA55 | |||||
Document link: | |||||
Document date: 2015-02-06 | |||||
Study number: 3681 | |||||
EudraCT number: | |||||
Scope of study: | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |